Global Keratolytic Agents Market, By Indication (Psoriasis, Dry Skin, Acne Vulgaris, Warts, Dandruff, Others), Dosage Form (Shampoo, Gel, Solution, Face Wash, Lotion, Creams, Others), Agents (Urea, Salicylic Acid, Lactic Acid, Alpha Hydroxy Acids, Propylene Glycol, Others), Route of Administration (Topical, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029
Keratolytic Agents Market Analysis and Size
The keratolytic agents market is expected to witness significant growth during the forecast period. Growing cases of dry skin, hair dandruff and face acne drives the keratolytic agents market. However, increased awareness about the keratolytic agents especially salicylic acid and alpha glycolic acid for beautification and medical purposes worldwide will boost the keratolytic agents market. Many major market players are contributing a lot in drug discovery and development. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global keratolytic agents market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Keratolytic agents are the type of compounds which break down the outer layer of skin and minimize the thickness of skin damage cells with the help of exfoliation. These agents are applied to soften the skin and is useful in treating several dry skin conditions. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Indication (Psoriasis, Dry Skin, Acne Vulgaris, Warts, Dandruff, Others), Dosage Form (Shampoo, Gel, Solution, Face Wash, Lotion, Creams, Others), Agents (Urea, Salicylic Acid, Lactic Acid, Alpha Hydroxy Acids, Propylene Glycol, Others), Route of Administration (Topical, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc. (U.S.), GSK plc (UK), Novartis AG (Switzerland), Mylan N.V. (U.S.), Boehringer Ingelheim International GmbH. (Germany), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Cadila Pharmaceuticals (India), Lilly (U.S.), LEO Pharma A/S (Denmark), Cipla Inc. (U.S.), Aurobindo Pharma (India), Lupin (India), Sumitomo Corporation (Japan), Taro Pharmaceutical Industries Ltd. (U.S.)
|
|
Market Opportunities
|
|
Global Keratolytic Agents Market Dynamics
Drivers
- Rising Incidence of Acne
Acne has become a very common skin disease affecting approximately 9.4% of the world's population with the highest occuring in adolescents. The prevalence is over 90% in males and 80% in females. The prevalence varies in many of the countries due to the climatic factors.
Opportunities
- Increasing Demand for Retail Pharmacies
The rise in the number of antacids delivered through these retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for the market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
- Rising Cases of Human papillomavirus (HPV)
The demand for keratolytic agents have increased as more than 16% of the population are suffering from sexually transmitted HPV and warts. Physicians are referring keratolytic agents to patients suffering with these disease. This factor boost the market growth.
Restraints/Challenges
- Complications of Keratolytic Agents
Some common side effects of keratolytic agents include redness, skin irritation, rashes, nausea, vomiting and such. Thus, it creates hindrance to the market growth.
- High Cost
The huge expenditure of the treatment methods surely hamper the market growth.
This global keratolytic agents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global keratolytic agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Keratolytic Agents Market
The covid-19 pandemicnegatively impactedn the global antacids market because the utmost priority was given to Covid-19 patients for treatment. The COVID-19 pandemic caused a tremendous increase in its sales, as most of the population were stressed, with improper diet and minimal exercise. In addition to this, several keratolytic agents were successful in treating many COVID-19 patients who were hospitalized. Thus, the COVID-19 outbreak increased the keratolytic agents market’s growth globally.
Global Keratolytic Agents Market Scope
The global keratolytic agents market is segmented on the basis of indication, dosage form, agents, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Psoriasis
- Dry Skin
- Acne Vulgaris
- Warts
- Dandruff
- Others
Dosage Form
- Shampoo
- Gel
- Solution,
- Face Wash
- Lotion
- Creams
- Others
Agents
- Urea
- Salicylic Acid
- Lactic Acid
- Alpha Hydroxy Acids
- Propylene Glycol
- Others
Route of Administration
- Topical
- Others
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global Keratolytic Agents Market Regional Analysis/Insights
The global keratolytic agents market is analysed and market size insights and trends are provided by indication, dosage form, agents, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global keratolytic agents market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to the presence of key manufacturer of the product, high research and development and healthcare expenditure and skilled professionals
Asia-Pacific dominates the market due to increased campaign programmes for products used for the skin care & beautification and number of generic drugs.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Keratolytic Agents Market Share Analysis
The global keratolytic agents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global keratolytic agents market.
Key players operating in the global keratolytic agents market include:
- Pfizer Inc. (U.S.)
- GSK plc (UK)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Boehringer Ingelheim International GmbH. (Germany)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Bayer AG (Germany)
- Merck & Co., Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Cadila Pharmaceuticals (India)
- Lilly (U.S.)
- LEO Pharma A/S (Denmark)
- Cipla Inc. (U.S.)
- Aurobindo Pharma (India)
- Lupin (India)
- Sumitomo Corporation (Japan)
- Taro Pharmaceutical Industries Ltd. (U.S.)
SKU-